Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "EPM Magazine" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about EPM Magazine for you to read. Along with our medical data and news we also list EPM Magazine Clinical Trials, which are updated daily. BioPortfolio also has a large database of EPM Magazine Companies for you to search.
Packaging supplier Sanner has announced it will showcase its portfolio of active and intelligent primary packaging solutions and medtech products at Pharmapack 2019.
DoseCare has acquired Biodose, a monitored dosage system (MDS) that accommodates liquid and solid medication.
Biotechnology company Lonza has announced an initiative with GE Healthcare in which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou, China (CN).
Pharmaceutical companies must make additional plans to prepare for a ‘no deal’ Brexit, health secretary Matt Hancock has said.
The life sciences sector in the North of England will receive £1.6 billion of investment over the next five years.
To celebrate the announcement of the Second Life Sciences Sector Deal, healthcare company IQVIA welcomed the UK’s minister for Trade and Export Promotion, baroness Rona Fairhead to its London office, earlier this week.
A “Norway Plus” Brexit will be the least damaging to the pharmaceutical manufacturing sector, according to an industry logistics expert.
Pharmaceutical giant GSK has announced a major acquisition of the biotech company Tesaro to help bolster its oncology pipeline.
The Life Sciences Sector Deal is being updated with a £46 million investment package as part of a collaboration with healthcare company IQVIA, the government has announced.
Innovative cancer drugs are taking longer to get to patients due to delays in clinical trials and regulatory red tape, new data shows.
A pioneering UK vaccine centre dedicated to tackling deadly diseases such as Ebola is to be built in Oxford, the government has announced.
A health sciences and regulatory company is expanding its services to the European Union’s medical device, pharmaceutical and manufacturing industries.
The Medicines and Healthcare products Regulatory Agency (MRHA) has announced a pharmacy level recall of a blood pressure drug made by Mylan and Teva.
13 trusts will be the first to receive a share of £78 million to support electronic prescribing and medicines administration (ePMA) to improve patient safety.
Innovate UK has awarded £1.5 million to a contract development and manufacturing organisation (CDMO) focused on advanced therapy medicinal products (ATMPs).
GE Healthcare has announced the opening of a new biotechnology centre in the UK to help improve the purification steps within manufacturing.
The NHS has negotiated the biggest saving for a single drug after securing deals with five manufacturers.
Biotechnology company Fluidic Analytics has raised $31 million to help it develop products that could provide insight into the way diseases develop.
A leading gene and cell therapy group has announced a new digital framework initiative to help streamline the production of next-generation medicines.
Concerns have been raised over the government’s contingency plans for whether the UK can ensure a suitable supply of medicines in the event of a ‘no deal’ Brexit.
Global developer of label design software, NiceLabel, has launched a cloud label management system, developed to allow businesses to digitally transform their factory and warehouse labelling process.
Patients could soon receive essential medicines faster thanks to the adoption of new digital technologies within manufacturing.
A new collaboration between the University of California, Los Angeles and biopharmaceutical company Helperby is looking to develop the next generation of combination antibiotics.
In the next 12 years, half of those with type 2 diabetes won’t be able to receive potentially life-saving insulin unless access to the drug improves, new research shows.
Brexit negotiators have a duty to protect millions of patients on both sides of the Channel, a coalition from the UK’s health sector has said.